Treating Opiate Use Disorder in Primary Care - Interview with Shelby Pope, NP

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/f6/fb/24/f6fb24e4-3286-9d8a-5a75-ca5d9aede0af/mza_45878657013925073.jpeg/600x600bb.jpg

Real World NP

Liz Rohr

121 episodes

8 months ago

Hi, I’m Liz Rohr: family nurse practitioner, wife, parent, and founder of Real World NP, a continuing education company for new nurse practitioners in primary care.

I’m on a mission to equip and guide new nurse practitioners so they can feel confident and capable through comprehensive, concise, and hyper-relevant educational resources, without the fluff. We’re also here to provide an approachable, supportive community in order to bring about a new generation of healthcare providers who know that they can make an impact & inevitably disrupt the healthcare industry.

Each week you’ll hear a mix of clinical pearls and practice tips, guest interviews with specialists and allied health professionals, and guidance on navigating the role transition from RN to NP. Make sure you subscribe and leave a review so you won’t miss an episode. Plus, you’ll find links to all the episodes, plus extra goodies over at realworldnp.com/podcast.

Hosted on Acast. See acast.com/privacy for more information.

All content for Real World NP is the property of Liz Rohr and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hi, I’m Liz Rohr: family nurse practitioner, wife, parent, and founder of Real World NP, a continuing education company for new nurse practitioners in primary care.

Hosted on Acast. See acast.com/privacy for more information.

Treating Opiate Use Disorder in Primary Care - Interview with Shelby Pope, NP

Real World NP

1 hour 11 minutes 13 seconds

1 year ago

Treating Opiate Use Disorder in Primary Care - Interview with Shelby Pope, NP

In this episode, Liz Rohr interviews Shelby Pope, DNP, APRN, FNP-BC, they discuss the stigma around addiction, the importance of supporting patients with opiate use disorder while exploring Shelby’s journey into addiction medicine and impacts of this field.

This episode includes discussion of various treatment options for opiate use disorder, including naltrexone and buprenorphine, including the importance of medication-assisted treatment (MAT) for opioid use disorder, while emphasizing the effectiveness of methadone and buprenorphine in reducing the risk of overdose and mortality.

Liz and Shelby explore the process of induction and the importance of assessing withdrawal symptoms, ongoing monitoring and support for patients on MAT, including addressing cravings and harm reduction strategies.

Key takeaways:

Exploring the stigma around addiction, and the importance of supporting patients with opiate use disorder.
Addiction medicine is a beautiful and impactful field that can be accessible in primary care.
Naltrexone and buprenorphine are two treatment options for opiate use disorder.
Open conversations with patients and providing support and resources are crucial in primary care.
Methadone may be necessary for some patients with extreme cases of opiate use disorder. Medication-assisted treatment (MAT) with methadone and buprenorphine is highly effective in reducing the risk of overdose and mortality in individuals with opioid use disorder.
Assessing withdrawal symptoms is crucial before starting buprenorphine to avoid precipitated withdrawal.
Ongoing monitoring and support are essential for patients on MAT, including addressing cravings and providing harm reduction strategies.
Tapering off medication should be done slowly and on an individualized basis, considering the patient's stability and goals.
Individualized care and empathetic communication are key in building trust and supporting patients on their recovery journey.

For a full transcript and conversation chapters, visit the blog: https://www.realworldnp.com/blog/opiate-use-disorder.

______________________________

Hosted on Acast. See acast.com/privacy for more information.